webadmin@phasesci.com

About webadmin@phasesci.com

This author has not yet filled in any details.
So far webadmin@phasesci.com has created 37 blog entries.

THE DIAGNOSTIC PARTNER: ADDRESSING THE EQUITY IMPLICATIONS OF HEALTH DIAGNOSTICS

February 27, 2023

Achieving health equity, in which everyone has a fair and just opportunity to attain their highest level of health, requires ongoing efforts to address historical and contemporary injustices, overcome barriers to healthcare access, and eliminate preventable health disparities. When it comes to diagnostics, the COVID-19 pandemic cast a harsh […]

THE DIAGNOSTIC PARTNER: ADDRESSING THE EQUITY IMPLICATIONS OF HEALTH DIAGNOSTICS2023-02-28T20:42:34+05:00

THE DIAGNOSTIC PARTNER: EXPANDING THE USE OF TEST-TO-TREAT IN THE POST-PANDEMIC WORLD

February 20, 2023

The federal COVID-19 Test-to-Treat program launched in March 2022 but the test-to-treat response to infectious disease isn’t new.  It does need renewal, however.

Test-to-treat describes an early intervention approach to infectious disease in which a patient gets tested as soon as possible and, if positive, promptly receives an appropriate treatment.  […]

THE DIAGNOSTIC PARTNER: EXPANDING THE USE OF TEST-TO-TREAT IN THE POST-PANDEMIC WORLD2023-02-21T23:34:03+05:00

PHASE SCIENTIFIC AMERICAS AND DR. B PARTNER TO MAKE IT EASIER THAN EVER TO TEST-TO-TREAT COVID-19 AT HOME

 

After Testing Positive with PHASE’s INDICAID® Rapid Antigen At-Home Test, Patients Can Now Conveniently Access Dr. B’s Low-Cost Telehealth Service for Antiviral Treatments

(GARDEN GROVE, CA,) – December 21st, 2022 – PHASE Scientific Americas, a health diagnostics innovator and maker of INDICAID® Rapid Antigen Tests, announces a new partnership […]

PHASE SCIENTIFIC AMERICAS AND DR. B PARTNER TO MAKE IT EASIER THAN EVER TO TEST-TO-TREAT COVID-19 AT HOME2022-12-21T01:32:39+05:00

OMICRON VARIANT UPDATE

November 21, 2022

Phase Scientific continuously monitors emerging variants of the virus that causes COVID-19 and how their mutations may impact the performance of the INDICAID® COVID-19 Rapid Antigen Test.

An independent evaluation by the National Institutes of Health (NIH) RADx Variant Task Force has determined that the INDICAID® test detects the […]

OMICRON VARIANT UPDATE2022-12-15T22:32:18+05:00

NEW YORK STATE SELECTS COVID-19 DIAGNOSTICS LEADERS TO EXPAND TESTING OPTIONS

Partnership between PHASE Scientific and BCalifornia to deliver over 30 million COVID-19 Test Kits

(ATLANTA, GA) – PHASE Scientific, a health diagnostics innovator and maker of INDICAID COVID-19 Rapid Antigen Tests, and BCalifornia, a family-owned and operated business dedicated to the health and wellness of all communities, announced that the […]

NEW YORK STATE SELECTS COVID-19 DIAGNOSTICS LEADERS TO EXPAND TESTING OPTIONS2022-12-30T08:41:02+05:00

NEW STUDY: EMPLOYERS’ COVID-19 TESTING SUPPORT FOR AT-HOME TESTING GROWS

But Test-To-Treat Adoption Remains Low

(ATLANTA, GA) Despite Americans’ most optimistic sentiments, COVID-19 is here to stay and so is its impact on employee health and absenteeism. PHASE Scientific Americas (PHASE) is a health diagnostics innovator and maker of INDICAID Rapid Antigen Tests. National Association […]

NEW STUDY: EMPLOYERS’ COVID-19 TESTING SUPPORT FOR AT-HOME TESTING GROWS2022-10-17T22:09:04+05:00

US GOVERNMENT SUSPENDING FREE AT-HOME COVID-19 TEST PROGRAM

The United States government is suspending its free COVID-19 at-home test program starting September 2nd, 2022.

As stated by the covid.gov site:

“Ordering through this program will be suspended on Friday, September 2 because Congress hasn’t provided additional funding to replenish the nation’s stockpile of tests.”

While you are out enjoying life, including […]

US GOVERNMENT SUSPENDING FREE AT-HOME COVID-19 TEST PROGRAM2022-09-13T20:37:55+05:00

Targeting COVID-19 Absenteeism with Test to Treat Approach

By Doug Field, Chief Revenue Officer, PHASE Scientific Americas

While the recent surges of current COVID-19 variants are not driving high levels of hospitalization and death, the persistent, circulating virus continues to affect employees and spike absenteeism across businesses of all sizes. The impact is serious, affecting not only day-to-day operations and productivity […]

Targeting COVID-19 Absenteeism with Test to Treat Approach2022-12-21T03:00:20+05:00
Go to Top